Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) General Counsel James S. Hanson sold 1,677 shares of the company's stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $10.23, for a total value of $17,155.71. Following the completion of the transaction, the general counsel directly owned 19,092 shares in the company, valued at approximately $195,311.16. This trade represents a 8.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Fortrea Trading Up 1.0%
Shares of FTRE stock traded up $0.10 on Monday, hitting $10.20. The stock had a trading volume of 1,236,217 shares, compared to its average volume of 1,847,848. The company has a debt-to-equity ratio of 1.87, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $926.16 million, a P/E ratio of -0.90 and a beta of 1.88. Fortrea Holdings Inc. has a 1 year low of $3.97 and a 1 year high of $25.28. The company's 50 day moving average price is $7.51 and its 200-day moving average price is $6.72.
Fortrea (NASDAQ:FTRE - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.13. Fortrea had a positive return on equity of 5.25% and a negative net margin of 37.57%.The firm had revenue of $710.30 million for the quarter, compared to the consensus estimate of $631.61 million. Analysts anticipate that Fortrea Holdings Inc. will post 0.51 earnings per share for the current year.
Analyst Ratings Changes
Several brokerages have weighed in on FTRE. Baird R W upgraded Fortrea from a "hold" rating to a "strong-buy" rating in a report on Monday, August 4th. Jefferies Financial Group upped their price objective on Fortrea from $7.00 to $9.50 and gave the stock a "hold" rating in a research report on Tuesday, September 9th. Citigroup reaffirmed a "neutral" rating on shares of Fortrea in a research report on Thursday, May 22nd. Barclays reaffirmed an "underweight" rating and set a $6.00 price objective (up from $5.00) on shares of Fortrea in a research report on Thursday, August 7th. Finally, Mizuho lowered their price objective on Fortrea from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Friday, July 11th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $11.50.
Read Our Latest Analysis on FTRE
Institutional Trading of Fortrea
A number of large investors have recently made changes to their positions in the company. Osaic Holdings Inc. boosted its position in shares of Fortrea by 74.3% in the 2nd quarter. Osaic Holdings Inc. now owns 6,844 shares of the company's stock valued at $38,000 after purchasing an additional 2,918 shares during the period. Thrivent Financial for Lutherans boosted its position in shares of Fortrea by 88.2% in the 2nd quarter. Thrivent Financial for Lutherans now owns 229,368 shares of the company's stock valued at $1,133,000 after purchasing an additional 107,522 shares during the period. State of Wyoming boosted its position in shares of Fortrea by 194.0% in the 2nd quarter. State of Wyoming now owns 73,638 shares of the company's stock valued at $364,000 after purchasing an additional 48,588 shares during the period. Hudson Bay Capital Management LP boosted its position in shares of Fortrea by 46.3% in the 2nd quarter. Hudson Bay Capital Management LP now owns 440,000 shares of the company's stock valued at $2,174,000 after purchasing an additional 139,188 shares during the period. Finally, Public Sector Pension Investment Board boosted its position in shares of Fortrea by 8.5% in the 2nd quarter. Public Sector Pension Investment Board now owns 308,551 shares of the company's stock valued at $1,524,000 after purchasing an additional 24,096 shares during the period.
Fortrea Company Profile
(
Get Free Report)
Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.
Featured Stories

Before you consider Fortrea, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fortrea wasn't on the list.
While Fortrea currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.